Fig. 6From: LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verificationSubgroups prognostic, univariate, multivariate Cox regression,and nomogram analysis of PROS1 in LGG. A–E Kaplan–Meier curves of high and low PROS1 expression in subgroups, including female (A), Age > 40 years (B), 1p/19q non-codeletion (C), SD&PD (D), and astrocytoma (E). F–G The univariate F and multivariate Cox regression G analysis of PRSO1 in LGG patients. H–I Risk factor associations diagram H and Sankey diagram I were used to depicted the overall prognostic trend and living status of the inner relationship. J The nomogram for predicting the probability of 1-, 3-, and 5- year OS for LGG patients. K Calibration plots of the nomogram for predicting the probability of OS at 1, 3, and 5 yearsBack to article page